Macrophages and tumor growth. II. Cell kinetics at the site of allogeneic tumor growth.

Abstract:

:The sponge matrix allograft model made possible the growth of an AKR lymphoma in a certain percentage of BALB/c mice making progressors (tumor-bearing) and regressors (tumor-rejecting) simultaneously available. Mice bearing either an AKR kidney allograft or a sponge alone were used as controls. The cell population infiltrating the sponge was evaluated 2, 5, 10, 15, and 21 days after subcutaneous implantation. It consisted of macrophages, lymphocytes, and neutrophils. There was no difference between groups on Day 2 and Day 5. From Day 10 onwards, tumor growth was evident with a clear cut separation between progressors and regressors. The latter behaved like the two control groups except for a significant increase in lymphocytes on Day 21. The progressors showed a striking increase in total cell count from Day 10 onwards. Macrophages were the major population with a maximum value of 201 X 10(6) as compared to 8 X 10(6) in the regressors; their phagocytic and lysosomal activity remained similar in all groups. The lymphocytes showed no variation in absolute numbers but, because of the high cell count in progressors, their ratio to macrophages reached 1:50 on Day 10, making up only 2% of the cell population. Neutrophils were significantly increased in progressors as compared with the other groups. It can be concluded that in the presence of a foreign body reaction a marked influx of macrophages accompanies allogeneic tumor growth.

journal_name

Cancer Invest

journal_title

Cancer investigation

authors

Barrera CN,Mazzolli AB,Bustuoabad OD,Andreetta AM,Pasqualini CD

doi

10.3109/07357908509040603

subject

Has Abstract

pub_date

1985-01-01 00:00:00

pages

7-13

issue

1

eissn

0735-7907

issn

1532-4192

journal_volume

3

pub_type

杂志文章
  • Targeting Glioma Stem Cells by Functional Inhibition of Dynamin 2: A Novel Treatment Strategy for Glioblastoma.

    abstract::Glioma stem cells (GSCs) play major roles in drug resistance, tumour maintenance and recurrence of glioblastoma. We investigated inhibition of the GTPase dynamin 2 as a therapy for glioblastoma. Glioma cell lines and patient-derived GSCs were treated with dynamin inhibitors, Dynole 34-2 and CyDyn 4-36. We studied abou...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357907.2019.1582060

    authors: Luwor R,Morokoff AP,Amiridis S,D'Abaco G,Paradiso L,Stylli SS,Nguyen HPT,Tarleton M,Young KA,O'Brien TJ,Robinson PJ,Chircop M,McCluskey A,Jones NC

    更新日期:2019-01-01 00:00:00

  • Phase II trial of paclitaxel in patients with soft-tissue sarcoma.

    abstract::The response rate (RR) to single-agent chemotherapy with doxorubicin or ifosfamide in patients with advanced soft-tissue sarcoma (STS) is in the range of 20%. Paclitaxel is clinically useful in treating several solid tumors and has demonstrated activity in a series of human sarcoma cell lines. Twenty-eight patients wi...

    journal_title:Cancer investigation

    pub_type: 临床试验,杂志文章

    doi:10.3109/07357909809011697

    authors: Casper ES,Waltzman RJ,Schwartz GK,Sugarman A,Pfister D,Ilson D,Woodruff J,Leung D,Bertino JR

    更新日期:1998-01-01 00:00:00

  • Peroxiredoxin overexpression in MCF-7 breast cancer cells and regulation by cell proliferation and oxidative stress.

    abstract::Peroxiredoxins are thiol-specific antioxidant proteins that protect cells from ROS-induced cell death and are elevated in several cancers. We found that five of the six mammalian peroxiredoxins are overexpressed in MCF-7 breast cancer cells at the mRNA and protein levels, compared to noncancerous MCF-10A cells. Inhibi...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357907.2013.802798

    authors: Tehan L,Taparra K,Phelan S

    更新日期:2013-07-01 00:00:00

  • A prospective pharmacologic evaluation of age-related toxicity of adjuvant chemotherapy in women with breast cancer.

    abstract::Despite increasing evidence of benefit from adjuvant chemotherapy, older women with breast cancer are commonly given less aggressive treatment than younger patients. Conflicting prior data regarding age-related toxicity prompted this prospective study. Forty-four women (aged 35-79 years) with early-stage breast cancer...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357900009012191

    authors: Dees EC,O'Reilly S,Goodman SN,Sartorius S,Levine MA,Jones RJ,Grochow LB,Donehower RC,Fetting JH

    更新日期:2000-01-01 00:00:00

  • Evaluation of drug delivery and survival impact of dose-intense relative to conventional-dose methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy in urothelial cancer.

    abstract::The efficacy of dose-intense methotrexate, vinblastine, doxorubicin, and cisplatin (M-VAC) chemotherapy relative to conventional-dose M-VAC in patients with advanced transitional cell carcinoma is unknown. The outcomes of 33 patients on two successive protocols using dose-intense M-VAC with granulocyte colony-stimulat...

    journal_title:Cancer investigation

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.3109/07357900009032829

    authors: Dodd PM,McCaffrey JA,Mazumdar M,Scher H,Higgins G,Boyle MG,Herr H,Bajorin DF

    更新日期:2000-01-01 00:00:00

  • Growth arrest in ovarian cancer cells by hTERT inhibition short-hairpin RNA targeting human telomerase reverse transcriptase induces immediate growth inhibition but not necessarily induces apoptosis in ovarian cancer cells.

    abstract::It is believed that telomerase is a terminal effector and its role is to maintain the length of telomeres. However, the main rate-limiting subunit of telomerase, human telomerase reverse transcriptase (hTERT), has been recently proved to have the ability to affect a variety of other genes such as p53 independently of ...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357900802491451

    authors: Luo Y,Yi Y,Yao Z

    更新日期:2009-12-01 00:00:00

  • Detection of Promoter DNA Methylation of APC, DAPK, and GSTP1 Genes in tissue Biopsy and Matched Serum of Advanced-Stage Lung Cancer Patients.

    abstract::Promoter DNA hypermethylation of APC, DAPK, and GSTP1 genes was evaluated in biopsy and matched serum of 160 lung cancer patients and 70 controls. In biopsy, 83.1, 83.1, and 78.1% of lung cancer patients and 72.9, 70, and 70% of controls, while in serum, 52.5, 30.6, and 65.6% of lung cancer patients and 14.3, 18.6, an...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357907.2017.1309547

    authors: Ali A,Kumar S,Kakaria VK,Mohan A,Luthra K,Upadhyay AD,Guleria R

    更新日期:2017-07-03 00:00:00

  • Transforming growth factor-beta 1 gene polymorphisms and expression in the blood of prostate cancer patients.

    abstract::The transforming growth factor beta 1 (TGF-beta1) is a multifunctional cytokine with several regulatory activities in tumor cells affecting growth, differentiation, and function. Alterations in gene expression, secretion, and regulation of TGF-beta1 may lead to a favorable environment for tumor development by angiogen...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900701600921

    authors: Faria PC,Saba K,Neves AF,Cordeiro ER,Marangoni K,Freitas DG,Goulart LR

    更新日期:2007-12-01 00:00:00

  • A phase II study of mitomycin C, etoposide, and cisplatin in advanced non-small cell lung cancer.

    abstract::Standard chemotherapeutic regimens, such as cisplatin and etoposide, may improve quality of life and prolong survival in patients with incurable non-small cell lung cancer (NSCLC). This trial was designed to evaluate the activity and toxicity of a regimen combining three of the most active agents against advanced-stag...

    journal_title:Cancer investigation

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.3109/07357900009023055

    authors: Ali MA,Kraut MJ,Valdivieso M,Wozniak AJ,Cummings G,Kalemkerian GP

    更新日期:2000-01-01 00:00:00

  • Association between interleukin-8 -251A/T polymorphism and risk of lung cancer: a meta-analysis.

    abstract::This study is to evaluate the association between IL-8 -251A/T polymorphism and lung cancer risk in diverse populations. We performed a meta-analysis of six case-control studies that included 3,265 lung-cancer cases and 3,607 case-free controls. Overall, results showed that the IL-8 -251A/T polymorphism was not associ...

    journal_title:Cancer investigation

    pub_type: 杂志文章,meta分析

    doi:10.3109/07357907.2014.964410

    authors: Gao P,Zhao H,You J,Jing F,Hu Y

    更新日期:2014-12-01 00:00:00

  • Phase II trial of 96-hour paclitaxel in previously treated patients with advanced esophageal cancer.

    abstract:BACKGROUND:A 96-hour infusion schedule of paclitaxel demonstrates tolerability and antitumor activity in lung cancer and breast cancer refractory to short-duration infusion paclitaxel. Given the activity of paclitaxel in esophageal cancer, a phase II trial of 96-hour infusion paclitaxel in esophageal cancer was underta...

    journal_title:Cancer investigation

    pub_type: 临床试验,杂志文章

    doi:10.1081/cnv-120022360

    authors: Anderson SE,O'Reilly EM,Kelsen DP,Ilson DH

    更新日期:2003-01-01 00:00:00

  • Experimental basis for cancer prevention by vitamin E.

    abstract::Recent clinical trials have demonstrated the significant cancer preventive potential of vitamin E in many different cancer sites, ranging from oral and pharyngeal cancer to prostate cancer. There is an extensive experimental basis for this clinical cancer inhibition. The experimental background includes animal studies...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.3109/07357900009031826

    authors: Shklar G,Oh SK

    更新日期:2000-01-01 00:00:00

  • Naturally occurring retroviruses (RNA tumor viruses). I.

    abstract::This is the first of two papers describing the naturally occurring retroviruses (RNA tumor viruses). Here, the general properties of these viruses and the biology of the fish, reptilian, chicken, and mouse retroviruses are described. In the next issue of Cancer Investigation the biologic properties of the cat, cattle,...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.3109/07357908309040934

    authors: Hardy WD Jr

    更新日期:1983-01-01 00:00:00

  • Infusional mitoxantrone plus bolus melphalan as a stem cell transplant conditioning regimen for multiple myeloma.

    abstract::This study combined infusional mitoxantrone with bolus melphalan as a transplant preparative regimen for multiple myeloma. Mitoxantrone was infused over 6 hr on days 6 and 5. Melphalan was given as a 15 min bolus on day 1 followed by autologous transplant on day 0. Thirty-five patients were enrolled; 57% of enrollees ...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357907.2010.550663

    authors: Beaven AW,Moore DT,Sharf A,Serody JS,Shea TC,Gabriel DA

    更新日期:2011-03-01 00:00:00

  • Interventional procedures for cancer pain management: when are they indicated?

    abstract::Non-invasive pharmacological management of patients with cancer related pain has resulted in pain control in 90-95% of the patients. Thus, 5-10% of patients still experience inadequate pain control despite aggressive combined pharmacological therapy. Moreover, patients may not tolerate an aggressive program of titrati...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1081/cnv-200027166

    authors: de Leon-Casasola OA

    更新日期:2004-01-01 00:00:00

  • Botanical medicines for the treatment of cancer: rationale, overview of current data, and methodological considerations for phase I and II trials.

    abstract::There appears to be exceptional and growing public enthusiasm for botanical, or "herbal", medicines, especially amongst cancer patients. This has recently begun to be matched by increasing scientific attention. Whilst it is known that plant extracts are active against cancer, the standard approach has been to isolate,...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1081/cnv-120005926

    authors: Vickers A

    更新日期:2002-01-01 00:00:00

  • Radiation recall dermatitis induced by edatrexate in a patient with breast cancer.

    abstract::Enhancement of radiation injury to the skin and mucous membranes has been observed with a number of chemotherapeutic agents. A 32-year-old woman with metastatic breast cancer received local radiation therapy to the lumbosacral area. Six weeks later, systemic edatrexate therapy was initiated and a localized painful ery...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357909509024929

    authors: Perez EA,Campbell DL,Ryu JK

    更新日期:1995-01-01 00:00:00

  • Circulating soluble CTLA4 (sCTLA4) is elevated in patients with breast cancer.

    abstract::Soluble CTLA4 (sCTLA4) was assessed in sera of 43 new cases with breast cancer and 44 age- and sex-matched healthy individuals by enzyme-linked immunosorbent assay method. Associations of sCTLA4 levels with the six important CTLA4 Single Nucleotide Polymorphisms (SNPs) and with the resulted haplotypes were investigate...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357901003630934

    authors: Erfani N,Razmkhah M,Ghaderi A

    更新日期:2010-10-01 00:00:00

  • CD147 impacts angiogenesis and metastasis formation.

    abstract::CD147 is highly expressed on many tumor cells; its role for tumor invasiveness and metastasis has been deduced from its capacity to induce MMPs, i.e., MMP-1, -2, -3, and -9. However, in the murine B16 melanoma model, MMP-2/-9 expression occurs independent of CD147. To scrutinize the impact of CD147 on metastasis forma...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900802392675

    authors: Voigt H,Vetter-Kauczok CS,Schrama D,Hofmann UB,Becker JC,Houben R

    更新日期:2009-03-01 00:00:00

  • Case-control study of breast cancer in India: Role of PERIOD3 clock gene length polymorphism and chronotype.

    abstract:BACKGROUND:This study examined a PERIOD3 (PER3) gene variable number tandem repeat polymorphism and chronotype as potential BrCA risk factors among Indian women. METHODS:This case-control study included sporadic, histologically confirmed BrCA cases (n = 255) and controls (n = 249) from India with data collection from ...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357907.2014.919305

    authors: Wirth MD,Burch JB,Hébert JR,Kowtal P,Mehrotra-Kapoor A,Steck SE,Hurley TG,Gupta PC,Pednekar MS,Youngstedt SD,Zhang H,Sarin R

    更新日期:2014-08-01 00:00:00

  • Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: report of two cases and review of literature.

    abstract::Placement of carmustine-impregnated wafers has become a common practice after surgical resection of malignant gliomas. Bevacizumab is used as a second-line agent for the treatment of malignant gliomas and is sometimes used in patients who have had recent wafer implantation. We describe two cases of fatal cerebrospinal...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.3109/07357907.2010.483499

    authors: Nagaiah G,Almubarak M,Khan M,Altaha R

    更新日期:2010-12-01 00:00:00

  • Possible Role and Therapeutic Target of PDGF-D Signalling in Colorectal Cancer.

    abstract::Platelet-derived growth factor D (PDGF-D) has been shown to mediate cellular processes of importance in cancer progression. This study aimed to investigate the expression and putative involvement of PDGF-D signaling in colorectal carcinogenesis. PDGF-D was expressed in vascular endothelial cells in tumor and normal ti...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357907.2019.1576191

    authors: Olsen RS,Dimberg J,Geffers R,Wågsäter D

    更新日期:2019-01-01 00:00:00

  • Type 2 Diabetes Associated with Abnormal p53 Immunohistochemical Patterns in Colorectal Cancer.

    abstract::Abnormal p53 immunohistochemical pattern (p53-AP) including overexpression, complete absence and heterogeneity is surrogate of TP53 mutation. Using 742 cases of colorectal cancer (CRC), we show p53-AP is more common among type 2 diabetes (T2DM) patients than non-T2DM. Univariately, T2DM was significantly associated wi...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357907.2020.1852411

    authors: Yang Z,Ma J,Qi G,Zhang X

    更新日期:2021-01-01 00:00:00

  • Contemporary treatment of borderline ovarian tumors.

    abstract::In conclusion, the prognosis for women with stage I borderline tumors is excellent. Surgery alone is the recommended treatment. For young patients, fertility-sparing surgery is optimal, with a small percentage eventually developing tumor in the contralateral ovary. For patients with advanced stage borderline tumors, 1...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.3109/07357909909021423

    authors: Gershenson DM

    更新日期:1999-01-01 00:00:00

  • Pleural Macrophages can Promote or Inhibit Apoptosis of Malignant Cells via Humoral Mediators Depending on Intracellular Signaling Pathways.

    abstract::Macrophages in malignant pleural effusions (MPEs) demonstrate a promalignant phenotype. They release mediators, which are a source of inflammation within the pleura. We established in vitro model proving that pleural macrophages isolated from effusions affect cancer cells in their pro- or anti-apoptotic activity via h...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357907.2018.1477158

    authors: Kaczmarek M,Rubis B,Frydrychowicz M,Nowicka A,Brajer-Luftmann B,Kozlowska M,Lagiedo M,Batura-Gabryel H,Sikora J

    更新日期:2018-01-01 00:00:00

  • Quantification of Plasma Cell-Free Circulating DNA at Different Stages of Colorectal Cancer.

    abstract::Cell-free circulating DNAs (cfcDNAs) have been recognized as promising biomarkers for a number of cancers. This study aimed to quantify the cfcDNA in colorectal cancer to assess its potential value as biomarker. Quantification of baseline cfcDNA was determined as the amount of free glyceraldehyde 3-phosphate dehydroge...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357907.2017.1408814

    authors: Agah S,Akbari A,Talebi A,Masoudi M,Sarveazad A,Mirzaei A,Nazmi F

    更新日期:2017-11-26 00:00:00

  • Human interleukin 2 gene is located on chromosome 4.

    abstract::The interleukin-2 (IL2) gene is assigned to human chromosome 4. A synthetic oligonucleotide representing bases 285 to 324 of the IL2 cDNA clone described by Taniguchi et al. [Nature (London) 302:305-310, 1983] was used as hybridization probe in Southern blots. Eco RI digests of DNA derived from 11 somatic mouse-human ...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357908409018440

    authors: Sykora KW,Kolitz J,Szabo P,Grzeschik KH,Moore MA,Mertelsmann R

    更新日期:1984-01-01 00:00:00

  • Molecular aspects of vitamin D anticancer activity.

    abstract::Environment may influence the development and prevention of cancer. Calcitriol has been associated with calcium homeostasis regulation. Many epidemiological, biochemical, and genetic studies have shown non-classic effects of vitamin D, such as its involvement in the progression of different cancers. Although vitamin D...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.3109/07357907.2012.721039

    authors: Picotto G,Liaudat AC,Bohl L,Tolosa de Talamoni N

    更新日期:2012-10-01 00:00:00

  • Signal transduction pathways involved in the lineage-differentiation of NSCs: can the knowledge gained from blood be used in the brain?

    abstract::Neural stem cells (NSC) are capable of differentiating toward neuronal, astrocytic, oligodendrocytic and glial lineages, depending on their spatial location within the central nervous system (CNS). Although, a lot of knowledge has been gained in the understanding of differentiation-specific signaling in hematopoietic ...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1081/cnv-200039679

    authors: Mondal D,Pradhan L,LaRussa VF

    更新日期:2004-01-01 00:00:00

  • The role of irreversible EGFR inhibitors in the treatment of non-small cell lung cancer: overcoming resistance to reversible EGFR inhibitors.

    abstract::Reversible epidermal growth factor receptor tyrosine kinase inhibitors are often used for the treatment of non-small cell lung cancer following failure of cytotoxic chemotherapy. While these agents are active in a subset of patients, most develop resistance and progress within the course of 1 year. In nearly half of t...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.3109/07357901003631072

    authors: Belani CP

    更新日期:2010-05-01 00:00:00